Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

News

News
Merck’s Investigational Activin Signaling Inhibitor Sotatercept Improved 6-Minute Walk Distance by 40.8 Meters at Week 24 vs Placebo in Adults With Pulmonary Arterial Hypertension on Background Therapy
03/06/2023
Sotatercept demonstrated statistically significant improvements in 8 of 9 secondary measures, including reduction in risk of clinical worsening or death Results presented today at ACC.23/WCC and published in The New England Journal of...
Sotatercept demonstrated statistically significant improvements in 8 of 9 secondary measures, including reduction in risk of clinical worsening or death Results presented today at ACC.23/WCC and published in The New England Journal of...
Sotatercept demonstrated...
03/06/2023
Vascular Disease Management
News
Cardiovascular Logistics Names New Chief Development Officer
03/02/2023
February 28, 2023 - Houma, Louisiana – Cardiovascular Logistics (CVL), the most comprehensive national cardiology platform, has named Steven Collins as Chief Development Officer to drive growth through both mergers and acquisitions and...
February 28, 2023 - Houma, Louisiana – Cardiovascular Logistics (CVL), the most comprehensive national cardiology platform, has named Steven Collins as Chief Development Officer to drive growth through both mergers and acquisitions and...
February 28, 2023 - Houma,...
03/02/2023
Vascular Disease Management
News
New Study Demonstrates Inferior Vena Cava (IVC) Filters Are Safe and Effective Way to Treat Venous Thromboembolism (VTE)
02/23/2023
Data show IVC filter use led to few adverse events, even when used prophylactically Feb. 23, 2023—Few adverse events are connected to the use of inferior vena cava (IVC) filters to help prevent deep vein blood clots from developing into...
Data show IVC filter use led to few adverse events, even when used prophylactically Feb. 23, 2023—Few adverse events are connected to the use of inferior vena cava (IVC) filters to help prevent deep vein blood clots from developing into...
Data show IVC filter use led to...
02/23/2023
Vascular Disease Management

Advertisement

News
Procyrion Announces Successful First-in-Human Cases With Aortix Pump to Prevent Acute Kidney Injury in Patients Undergoing Cardiac Surgery
02/23/2023
Houston, Tx — Procyrion, Inc., a medical device company dedicated to improving outcomes for patients with cardiac and renal impairment, announced today successful treatment of the first patients in the A PRIORI (Aortix therapy...
Houston, Tx — Procyrion, Inc., a medical device company dedicated to improving outcomes for patients with cardiac and renal impairment, announced today successful treatment of the first patients in the A PRIORI (Aortix therapy...
Houston, Tx — Procyrion, Inc., a...
02/23/2023
Cath Lab Digest
News
Reprocessed Single-Use Devices in EP and Cath Labs: Innovative Health Presents Sustainability Awards to Hospitals Leading the Way in Responsible Device Use
02/23/2023
SCOTTSDALE, Ariz. – Innovative Health, Inc. announced that the hospital recipients of its annual sustainability awards reduced their carbon emissions by an average of 7,219 pounds in 2022, while simultaneously saving an average of $544,662 on...
SCOTTSDALE, Ariz. – Innovative Health, Inc. announced that the hospital recipients of its annual sustainability awards reduced their carbon emissions by an average of 7,219 pounds in 2022, while simultaneously saving an average of $544,662 on...
SCOTTSDALE, Ariz. – Innovative...
02/23/2023
Cath Lab Digest
News
PRESERVE Study Demonstrates Inferior Vena Cava (IVC) Filters are Safe and Effective Way to Treat Venous Thromboembolism (VTE)
02/23/2023
PRESERVE is an FDA-directed multicenter, prospective, open-label, non-randomized trial that studied the safety and efficacy of IVC filters from six manufacturers.
PRESERVE is an FDA-directed multicenter, prospective, open-label, non-randomized trial that studied the safety and efficacy of IVC filters from six manufacturers.
PRESERVE is an FDA-directed...
02/23/2023
Cath Lab Digest

Advertisement

News
BIOTRONIK Announces Its Latest Innovation: Oscar Multifunctional Peripheral Catheter
02/14/2023
Groundbreaking New All-In-One Device is First to Offer a Combination of Adjustable Guidewire Support Strength and Length-Adjustable Angioplasty Balloon to Reach, Cross and Prepare PAD Lesions February 14, 2023 – BUELACH, Switzerland –...
Groundbreaking New All-In-One Device is First to Offer a Combination of Adjustable Guidewire Support Strength and Length-Adjustable Angioplasty Balloon to Reach, Cross and Prepare PAD Lesions February 14, 2023 – BUELACH, Switzerland –...
Groundbreaking New All-In-One...
02/14/2023
Vascular Disease Management
News
Asundexian Phase III Trial Critical for Bayer to Become Market Leader in Anticoagulation to Prevent Stroke in AF Patients, Says GlobalData
02/14/2023
February 14, 2023 - Following the enrollment of the first patient in Bayer’s Phase III OCEANIC-AF clinical trial of asundexian, a potential anticoagulant for stroke prevention in atrial fibrillation (AF) patients, Amy Murray, Healthcare...
February 14, 2023 - Following the enrollment of the first patient in Bayer’s Phase III OCEANIC-AF clinical trial of asundexian, a potential anticoagulant for stroke prevention in atrial fibrillation (AF) patients, Amy Murray, Healthcare...
February 14, 2023 - Following...
02/14/2023
Vascular Disease Management
News
Concept Medical Granted Investigational Device Exemption (IDE) Approval for Their Magic Touch Sirolimus Coated Balloon for the Treatment of Below the Knee (BTK) Arterial Disease
02/13/2023
  Concept Medical Inc. (CMI), on 9th February 2023, received the Investigational Device Exemption (IDE) from the US FDA, for its Magic Touch Sirolimus Coated Balloon. The Magic Touch PTA Sirolimus Coated Balloon Catheter is...
  Concept Medical Inc. (CMI), on 9th February 2023, received the Investigational Device Exemption (IDE) from the US FDA, for its Magic Touch Sirolimus Coated Balloon. The Magic Touch PTA Sirolimus Coated Balloon Catheter is...
  Concept Medical...
02/13/2023
Vascular Disease Management

Advertisement

News
CIS Launches National Cardiology Platform in Partnership With Lee Equity Partners
02/01/2023
HOUMA, LA – February 1, 2023 – Cardiovascular Institute of the South (CIS), one of the largest independent cardiovascular practices in the country, announced the launch of a national cardiovascular platform, Cardiovascular Logistics, in...
HOUMA, LA – February 1, 2023 – Cardiovascular Institute of the South (CIS), one of the largest independent cardiovascular practices in the country, announced the launch of a national cardiovascular platform, Cardiovascular Logistics, in...
HOUMA, LA – February 1, 2023 –...
02/01/2023
Vascular Disease Management

Advertisement

Advertisement

Stay in the Know

Vascular Disease Management Newsletter

Advertisement

Advertisement

News

Sleep and CVD
Study of Sleep in Women Shows Delaying Bedtime by Just 90 Minutes Each Night Damages Endothelial Cells
08/06/2024
After just six weeks of shortened sleep, the study found, the cells that line our blood vessels are flooded by damaging oxidants. And unlike well-rested cells, sleep-restricted cells fail to activate antioxidant responses to clear the...
After just six weeks of shortened sleep, the study found, the cells that line our blood vessels are flooded by damaging oxidants. And unlike well-rested cells, sleep-restricted cells fail to activate antioxidant responses to clear the...
After just six weeks of...
08/06/2024
Cath Lab Digest
Peripheral Interventions
VentureMed Completes Enrollment of the FLEX Vessel Prep System FLEX First AV Registry For The Treatment of Arteriovenous (AV) Access Management
07/30/2024
The FLEX Vessel Prep System has a unique non-balloon-based mechanism of action that creates longitudinal micro-incisions that release circumferential tension in diseased vessels. This release of tension is how FLEX modifies AV stenoses to...
The FLEX Vessel Prep System has a unique non-balloon-based mechanism of action that creates longitudinal micro-incisions that release circumferential tension in diseased vessels. This release of tension is how FLEX modifies AV stenoses to...
The FLEX Vessel Prep System has...
07/30/2024
Cath Lab Digest
Peripheral Interventions
Transit Scientific’s Novel XO Cath Microcatheter Breaks New Ground in Transradial Embolic Delivery Procedure
07/30/2024
​ Transit Scientific, a Utah-based medical device company specializing in innovative solutions for vascular procedures, announced a milestone achievement with the successful utilization of XO Cath, its pioneering embolic delivery...
​ Transit Scientific, a Utah-based medical device company specializing in innovative solutions for vascular procedures, announced a milestone achievement with the successful utilization of XO Cath, its pioneering embolic delivery...
​ Transit Scientific, a...
07/30/2024
Cath Lab Digest
Carotid Artery Revascularization
Silk Road Medical Celebrates Milestone of 100,000 Transcarotid Artery Revascularization (TCAR) Procedures
07/30/2024
Transcarotid Artery Revascularization (TCAR) is a clinically proven procedure combining surgical principles of neuroprotection with minimally invasive endovascular techniques to treat blockages in the carotid artery at risk of causing a...
Transcarotid Artery Revascularization (TCAR) is a clinically proven procedure combining surgical principles of neuroprotection with minimally invasive endovascular techniques to treat blockages in the carotid artery at risk of causing a...
Transcarotid Artery...
07/30/2024
Cath Lab Digest
Health Care Needs
JACC: Almost Half of U.S. Counties Have No Cardiologists Despite Higher Prevalence of CV Risk Factors, Mortality
07/29/2024
Upon analyzing all 3,143 U.S. counties, it was determined that 1,454 counties (46.3%) with 22 million residents had no cardiologists while the other 1,689 counties each had 24 cardiologists on average. 86.2% of rural counties had no...
Upon analyzing all 3,143 U.S. counties, it was determined that 1,454 counties (46.3%) with 22 million residents had no cardiologists while the other 1,689 counties each had 24 cardiologists on average. 86.2% of rural counties had no...
Upon analyzing all 3,143 U.S....
07/29/2024
Cath Lab Digest
Renal Denervation
First Patients Treated in Recor Medical’s Global Paradise System US Post Approval Study (US GPS) for the Treatment of Uncontrolled Hypertension With Ultrasound Renal Denervation
07/25/2024
The study will focus on gathering real-world safety and effectiveness data over five years from up to 1,000 patients, collaborating with research centers to help advance diversity and health equity within clinical trials. Building upon the...
The study will focus on gathering real-world safety and effectiveness data over five years from up to 1,000 patients, collaborating with research centers to help advance diversity and health equity within clinical trials. Building upon the...
The study will focus on...
07/25/2024
Cath Lab Digest
Ischemic Stroke
Imperative Care Announces Clinical Data from the Pivotal Imperative Trial Evaluating the Zoom Reperfusion System for the Treatment of Ischemic Stroke
07/24/2024
“The observed data showed all three pre-specified performance goals were met. These data suggest a lower rate of rescue therapy than prior thrombectomy trials and may demonstrate that intracranial positioning of a super-large bore catheter...
“The observed data showed all three pre-specified performance goals were met. These data suggest a lower rate of rescue therapy than prior thrombectomy trials and may demonstrate that intracranial positioning of a super-large bore catheter...
“The observed data showed all...
07/24/2024
Cath Lab Digest
LINC
News
HMP Global’s Leipzig Interventional Course (LINC) Announces 20th Anniversary Congress in January 2025
07/22/2024
LINC, the world’s premier interdisciplinary live course for vascular and endovascular teams, announced that its annual meeting is shifting from summer to winter, with its 20th anniversary Congress in January 2025.
LINC, the world’s premier interdisciplinary live course for vascular and endovascular teams, announced that its annual meeting is shifting from summer to winter, with its 20th anniversary Congress in January 2025.
LINC, the world’s premier...
07/22/2024
Vascular Disease Management
News
Life Seal Vascular Inc. Awarded Prestigious NSF SBIR Grant to Advance Innovative Endovascular Aortic Aneurysm Sac Management Technology
07/17/2024
More than $274,000 in NSF funding to develop breakthrough aneurysm sac management technology
More than $274,000 in NSF funding to develop breakthrough aneurysm sac management technology
More than $274,000 in NSF...
07/17/2024
Vascular Disease Management
Ischemic Stroke
Imperative Care Announces FDA Clearance and Initial Cases of the Zoom 6F Insert Catheters, the First Insert Catheters Built for Stroke
07/17/2024
Based on physician feedback, the new Zoom 6F Insert Catheters were developed to be more supportive, more torque-able and longer than current vessel selection devices and are offered in three stroke-specific shapes.
Based on physician feedback, the new Zoom 6F Insert Catheters were developed to be more supportive, more torque-able and longer than current vessel selection devices and are offered in three stroke-specific shapes.
Based on physician feedback, the...
07/17/2024
Cath Lab Digest

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use